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Abstract
The oral cavity is relatively a common site for pigmented lesions, most of them being 
benign, but rarely they may be malignant. Hence, dentist should keep the possibility of 
malignant melanoma in mind during any diﬀ erential diagnosis of a pigmented lesions. 
The incidence of oral malignant melanoma is <1% of all melanomas and 1.6% of all 
head and neck malignancies. Although it accounts to be relatively a rare disease, it is a 
deadly one with a bad prognosis. We report a case of malignant melanoma for its rarity in 
mandibular gingiva and to emphasize the importance of early diagnosis and therapeutic 
intervention.
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Introduction
Although oral malignant melanoma accounts to be relatively a 
rare disease, it is a deadly one with a very bad prognosis. The 
incidence of oral malignant melanoma is <1% of all melanomas 
and 1.6% of all head and neck malignancies.[1] It occurs due 
to uncontrolled growth of melanocytes in the basal layer of 
oral mucousa.[2] Its etiology is unknown. Possible etiological 
factors include: Use of tobacco, mechanical trauma, exposure to 
formaldehyde, and alcohol. Sometimes it can also occur on pre-
existing long-term melanosis.[3]
It is having a higher incidence in yellows, blacks, Japanese, 
and Indians of Asia due to the more frequent fi nding of melanin 
pigmentation in oral mucosa of these races. It occurs between 30 
and 90 years of age, with a higher incidence in the 6th decade.[2]
Symptoms for which a patient seeks an oral physician’s opinion 
is a rapid spreading discoloration of the oral mucosa. Some other 
uncommon features include tooth mobility, paresthesia, swelling, 
ulceration, hemorrhage, and pain in advanced cases.[4]
The clinical diagnostic criteria of melanoma is known as 
ABCDE criteria [Table 1].[4,5] Green et al. has stated few criteria 
for the diagnosis of primary oral melanoma which includes.
• Demonstration of melanoma in the oral mucosa
• Presence of junctional activity
• Inability to demonstrate extraoral primary melanoma.[2]
We report a case of primary malignant melanoma of the left 
mandibular posterior gingiva.
Case Report
A 30-year-old male patient presented with a blackish 
pigmentation on the left mandibular posterior region with the 
history of noticing it since 3 months. A dentist noticed it on 
routine checkup in a private clinic, otherwise not associated with 
pain or any other symptoms.
The lesion extended from the medial aspect of 33 to distal 
aspect of 38 measuring about 7 cm × 5 cm. The lesion was nodular 
with brownish-black pigmentation. The growth had an intact 
Table 1: Th e “ABCDE” clinical diagnostic criteria of melanoma
A Asymmetry (because of its uncontrolled growth pattern)
B Border irregularity (oft en with notching)
C Color variegation (which varies from shades of brown to 
black, white, red, and blue, depending on the amount and 
depth of melanin pigmentation)
D Diameter>6 mm (which is the diameter of a pencil eraser)
E Evolving (lesions that have changed with respect to size, 
shape, color, surface, or symptoms over time
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surface with well-defi ned margins. The lesion was extending 
both bucally and lingually in marginal and attached gingival 
[Figure 1]. Orthopantamograph showed no signifi cant bone 
pathology. Left submandibular lymphnode was palpable, 2 cm in 
size, mobile, fi rm in consistency, and non-tender. An incisional 
biopsy was taken from the buccal marginal and attached gingiva.
Microscopic examination of H and E stained sections 
showed dysplastic stratifi ed squamous surface epithelium with 
proliferating atypical melanocytes in the radial and vertical 
pattern, along the basal cell layer and invading downward into 
the connective tissue [Figure 2]. Atypical cells were epithelioid 
in shape with vesiculated nuclei and prominent nucleoli. Varying 
degrees of nuclear pleomorphism and hyperchromatism were 
seen. Lesional cells showed fi ne melanin granules [Figure 3]. 
Mitotic fi gures were rare. A section bleached with hydrogen 
peroxide showed loss of brown melanin pigment [Figure 4]. In 
correlation with clinical features, the histopathological diagnosis 
of malignant melanoma of gingiva was made.
Discussion
Many pigmented lesions such as nevus, amalgam tattoo, 
melanotic macule, smoker’s melanosis, drug-induced 
pigmentation, systemic diseases, racial pigmentation and, of 
course, melanoma can occur in the oral cavity.[1] Although 
most of them are benign, clinicians must be able to diﬀ erentiate 
between benign lesions and the rare, deadly malignancies like 
melanoma.
During embryologic development, melanocytes migrate 
from the neural crest into the epithelium of the skin, and they 
reside primarily in the basal layer. Similar to skin, the epithelial 
lining of the oral mucosa, normally contains melanocytes in its 
basal layer, which can evolve into melanoma as in the skin.[1]
The pathogenesis of oral melanomas is poorly understood. 
They are believed to arise either from nevus, pre-existing 
pigmented areas, Hutchinson’s premalignant lentigo or denovo 
30% cases.[6] Some melanoma-associated antigens become 
expressed during transformation process from a benign 
Figure 3: Lesional cells showed fi ne melanin granules under H and 
E stain (×40 - high power)
Figure 4: A section bleached with hydrogen peroxide showed loss 
of brown melanin pigments under H and E stain (×40 - high power)
Figure  1: Nodular growth with brownish-black pigmentation, 
intact surface, and well-defi ned margins
Figure 2: Proliferating atypical melanocytes in radial and vertical 
pattern, along the epithelium and invading downward into the 
connective tissue under H and E stain (×10 - low power)
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melanocytic nevus to melanoma; the majorities of these are 
related to the melanin production process and most are HLA-
restricted.[6] The loss of heterozygosity at 12p13 and p27KIP1 
protein expression contributes to melanoma progression. 
Alterations in p53 gene have been identifi ed in two-third of the 
cases. Evaluation of melanocyte-specifi c gene1 and cytogenetic 
analysis appears to be helpful in understanding the pathogenesis 
of oral malignant melanoma.[2]
Oral melanomas may present as painless, fl at, black, or dark 
brown discoloration macules or nodules. Sometimes erythema or 
ulceration may also be seen. However, bony erosion is common 
only in the progressed disease.[7] Pigmentation is absent in 
amelanotic melanomas. Oral melanoma initially is characterized 
by radial growth followed by vertical growth phase.[6] Most of the 
melanomas are painless in their early stages; pain may be the later 
manifestation from ulceration, growth, or bleeding. Therefore, 
diagnosis is often unfortunately delayed.[2] Since there was no 
pain in our case, could have caused a delay in seeking treatment.
Clinically, oral melanomas are classifi ed into fi ve types: 
Pigmented macular, pigmented nodular, non-pigmented 
nodular, pigmented mixed, and non-pigmented mixed.[6] This 
case was clinically classifi ed as pigmented nodular type. A biopsy 
is mandatory when a pigmented lesion cannot be confi dently 
diagnosed as benign on clinical grounds, an incisional biopsy 
from the most suspicious part of the tumor in case of a large lesion 
and an excisional biopsy with 1 mm margin for small lesions 
is required. Exfoliative cytology and fi ne-needle aspiration of 
primary pigmented lesions is contraindicated. Cutting into 
a malignant neoplasm during an incisional biopsy or other 
invasive procedure could result in accidental dissemination of 
malignant cells within the adjacent tissues (seeding), lymphatic 
stream, or blood. This leads to the subsequent risk of, regional or 
distant metastasis or local recurrence. The most common sites 
of metastasis are bone, brain, liver, and lung.[6] Bhullar et al. and 
Austin et al. stated that there was reduced survival rate in patients 
with melanoma who had incisional biopsies, but this was against 
the studies done by Lederman and Sober where they found no 
correlation in patient’s prognosis with incisional and excisional 
biopsies.[2] If cervical lymphadenitis is present, FNAC should be 
performed to check for neoplastic cells.[4]
A protocol has been highlighted for approaching a patient 
with oral pigmentations:
1. All oral pigmented lesions that could not be clinically 
diagnosed should be biopsied
2. Biopsy should be performed from the thickest and darkest 
region of the lesion
3. Pathologists should be provided with complete clinical 
information for biopsies
4. Follow-up of the patient should be done which includes 
thorough check up, chest X-ray, and clinical photographs.[4]
Histologically we fi nd the proliferation of atypical 
melanocytes with a wide variety of shapes, such as spindle, 
plasmacytoid, epithelioid cells, and some clear cells.[3] Atypical 
melanocytes are seen in the junction of epithelial and connective 
tissue, as well as invading into deeper connective tissue. Special 
techniques such as bleaching can also be useful for conformative 
diagnosis.[4] Oral malignant melanoma can be usually diagnosed 
with confi dence on hematoxylin and eosin-stained sections. 
Immunohistochemical stains are of signifi cant help in case of 
amelanotic melanoma where the pigment is completely absent.[2] 
The useful diagnostic immunohistochemistry markers include: 
NKI/C-3, gp100 (HMB-45), Mart-1 (Melan-A), S-100 protein, 
tyrosinase, microphthalmia transcription factor, and vimentin.
A very important point in the management of malignant 
melanoma of the oral cavity is to exclude the possibility of it 
being a metastasis from cutaneous melanoma. This is because 
metastasis plays a large role in determining the goals and method 
of treatment.[7] Primary oral melanoma commonly involves 
hard palate (32%) maxillary gingiva (16%), mandibular gingiva 
(7%), tongue (7%), buccal mucosa (7%), and upper and lower 
lip (7%). When the lesion is secondary or metastatic, they are 
more commonly present in tongue, parotid, and tonsils.[4] In the 
histopathologic distinction, Billings et al. found that all metastatic 
lesions showed no evidence of junctional activity in the overlying 
mucosa and epidermal migration was also absent. This was in 
contrast to the primary lesion which had junctional activity 
and epidermal migration. Any suggested cutaneous or mucosal 
melanoma lesions elsewhere in the body should be absent for the 
diagnosis of primary oral mucosal melanoma. For our case, there 
was no history of melanoma-like lesion excision. We did not fi nd 
any cutaneous lesions suggestive of malignant melanoma over 
other parts of the body. The histopathological fi ndings revealed 
proliferating atypical melanocytes along the basal cell layer and 
invading downward into the connective tissue, suggesting that 
the tumor was a primary rather than a metastatic lesion.[7]
There is no well-defi ned pathological and clinical classifi cation 
for oral melanoma. Clark’s criteria of the cutaneous melanoma 
for the invasion level and the prognosis are not applicable to oral 
melanomas due to the lack of histological points of reference 
similar to the papillary and reticular dermis. But, few studies 
have compared oral melanomas with the cutaneous nodular 
melanoma and acral lentiginous melanoma.[3]
The American Joint Committee on Cancer have not given 
the guidelines on the staging of oral malignant melanomas. 
However, the guideline usually followed is a clinical classifi cation: 
Stage I - Clinically localized disease, Stage II - regional lymph 
node disease, and Stage III - distant disease.[2]
According to Westbury, a clinical classifi cation is as follows: 
1 - only primary tumor present, and 2 - metastasis present, 
2a - adjacent skin involved, 2b - adjacent lymph nodes involved, 
and 2ab - adjacent skin and lymph nodes involved.[2]
Western Society of Teachers of Oral Pathology classify 
according to the histopathological pattern: (a) melanoma in situ, 
delimited to the epidermis and its junction with the connective 
tissue; (b) invasive melanomas, in which the neoplasia extends 
into the connective tissue, and (c) melanomas with a combined 
pattern between invasive and in situ.[3]
Tumor node metastasis clinical staging system of good 
prognostic value can be followed, which divides into three stages. 
A recent histopathological micro staging for Stage I sub classifi es 
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it into three levels. Stage I: Primary tumor present only (T any, 
N0, M0). Level I: Pure in situ melanoma without evidence of 
invasion or in situ melanoma with “micro invasion,” Level II: 
Invasion up to the lamina propria, rand Level III: Deep skeletal 
tissue invasion into skeletal muscle, bone, or cartilage. Stage II: 
Tumor metastatic to regional lymph nodes (T any, N1, M0). 
Stage III: Tumor metastatic to distant sites (T any, N any, M1).[6]
Controversies exist regarding the best treatment for 
oral malignant melanoma. Several studies state that radical 
resection of the primary lesion as the treatment of choice. 
A combination therapy of surgery, chemotherapy, radiotherapy, 
and immunotherapy should be considered.[2] Immunological 
therapies have gained importance in recent years. Widely used 
cytokines are interleukin-2 and interferons.[7]
Prognosis of this malignancy remains poor, despite 
the improvement in surgical techniques and use of new 
chemotherapeutic agents. Clinical stage at presentation is 
probably the most important factor in determining the prognosis. 
Liu et al. stated that thickness of the tumor, cervical lymph node 
metastasis, presence or absence of ulceration, and the anatomic 
sites are all independent risk factors.[2]
The 5 years survival rate of primary oral melanoma is poor 
(15%) as compared to cutaneous melanoma (80%).
There can be several reasons for poor prognosis in primary 
oral melanoma:
1. Late diagnosis
2. Anatomic limitations making radicalsurgery diﬃ  cult
3. Mucosal tumors show rapid invasion to deeper structures
4. Vascularity of oral mucous membrane
5. The mucous membrane is thinner than skin because of 
thinner lamina propria due to thin papillary dermis and 
absence of reticular dermis. Thus most mucosal melanomas 
progress quickly to vertical growth phase and gain access to 
the rich vascular and lymphatic network more quickly.[4]
A careful oral examination and early biopsy will usually result 
in an early diagnosis thus improving the prognosis to a signifi cant 
extent. In addition, public education about self-examination of 
the oral cavity with periodic oral checkup is important for early 
detection of such lesions.[8] In our case, the prognosis would have 
been much better, if the patient had reported earlier when the 
lesion was fl at and smaller in size; the 3 months delay resulted in 
the primary lesion being nodular and larger extending from the 
medial aspect of 33 to distal aspect of 38 measuring7 cm × 5 cm.
Conclusion
The pigmented lesions in the oral cavity may show high potential 
growth and pose diagnostic challenges to a clinician. Hence, 
early biopsy and thorough clinical diagnostic workup of the 
pigmented lesion will lead to early diagnosis and therapeutic 
intervention, thereby improving the prognosis of the patients 
with oral malignant melanoma. The case is reported for its rarity 
in the mandibular gingiva .
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